Otonomy Analyst Ratings

Benzinga Analyst RatingsOct 13, 2022 14:59 ET

Piper Sandler Downgrades Otonomy to Neutral From Overweight, Lowers Price Target to $0.50 From $3

MT NewswiresOct 13, 2022 12:40 ET

Otonomy Cut to Neutral From Buy by HC Wainwright & Co.

Dow JonesAug 2, 2022 06:29 ET

Otonomy analyst ratings

Benzinga Analyst RatingsAug 2, 2022 06:20 ET

Piper Sandler Adjusts Otonomy Price Target to $3 From $6, Maintains Overweight Rating

MT NewswiresAug 1, 2022 12:28 ET

Analysts Offer Insights on Healthcare Companies: Veru (VERU), Otonomy (OTIC) and Karuna Therapeutics (KRTX)

TipRanksJul 26, 2022 06:20 ET